SCHEMBL18171779

SCHEMBL18171779

CC(C)(C)OC(=O)Cn1c(=O)n(CC(=O)OC(C)(C)C)c2ccccc21

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 3/20 0.64
▸ KDM4E B2RXH2 3/20 0.62
▸ NPC1 O15118 1/20 0.59
▸ GAA P10253 1/20 0.59
▸ KMT2A Q03164 3/20 0.57
▸ MEN1 O00255 2/20 0.57
▸ APEX1 P27695 1/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.54
▸ POLB P06746 2/20 0.45
▸ TSHR P16473 1/20 0.43
▸ LMNA P02545 1/20 0.42
▸ CNR2 P34972 1/20 0.42
▸ PSEN1 P49768 1/20 0.42
▸ PSEN2 P49810 1/20 0.42
▸ APH1B Q8WW43 1/20 0.42
▸ NCSTN Q92542 1/20 0.42
▸ APH1A Q96BI3 1/20 0.42
▸ PSENEN Q9NZ42 1/20 0.42
▸ HSD17B10 Q99714 1/20 0.41
▸ THRB P10828 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3571941 0.91 ALDH1A1 (0.56) ALDH1A1KDM4ENPC1GAAKMT2A
SCHEMBL2762363 0.90 ALDH1A1 (0.54) ALDH1A1KDM4ENPC1GAAKMT2A
SCHEMBL19410130 0.85 ALDH1A1 (0.49) ALDH1A1KDM4ENPC1GAAKMT2A
Hydrochloric Acid SCHEMBL19410134 0.84 ALDH1A1 (0.48) ALDH1A1KDM4ENPC1GAAKMT2A
SCHEMBL20967569 0.84 ALDH1A1 (0.49) ALDH1A1KDM4ENPC1GAAKMT2A
SCHEMBL13332556 0.84 ALDH1A1 (0.50) ALDH1A1KDM4ENPC1GAAKMT2A
SCHEMBL19420852 0.83 ALDH1A1 (0.47) ALDH1A1KDM4ENPC1GAAKMT2A
SCHEMBL3182112 0.83 KDM4E (0.58) ALDH1A1KDM4EKMT2ASMN1; SMN2PSEN1
SCHEMBL18171837 0.83 ALDH1A1 (0.49) ALDH1A1KDM4ENPC1GAAKMT2A
SCHEMBL18171783 0.82 ALDH1A1 (0.46) ALDH1A1KDM4ENPC1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180072997-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION BRISTOL-MYERS SQUIBB COMPANY 2018-03-15 — — US disclosed
EP-3286174-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV Healthcare UK (No.5) Limited (GB) 2018-02-28 — — EP disclosed
WO-2016172425-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION VIIV HEALTHCARE (NO.5) LIMITED (GB) 2016-10-27 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180072997-A1 INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION EIF2AK2, POLR2H, POLR2E ALDH1A1 2545/4885KDM4E 2426/4885NPC1 273/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback